Bill and Danielle Gottfried, the founders of The Kidney Research Institute of Texas, continue to push forward in 2021 to help advance investment in kidney disease prevention, including the development of nutrition, dietary management, and life style management programs; kidney disease research, including identifying the leading kidney research institutions worldwide that warrant additional funding to advance kidney disease research; and advanced technology innovation, including the identification of leading technology innovators, worldwide, developing new dialysis technology platforms and renal replacement therapies, including technology innovation leading to the development of an artificial kidney. We remain committed to improving the lives of kidney patients and those at risk for kidney disease by supporting prevention, research, and technology innovation investment to improve the lives of the kidney patient community. One-third of the world’s population is at risk for kidney disease. Our goal is to help end the global pandemic of kidney disease.
The Kidney Research Institute of Texas Pushes Forward to Advance Improvements in Kidney Patient Care
Published by Bill and Danielle Gottfried, Founders of The Kidney Research Institute of Texas
Bill and Danielle Gottfried established The Kidney Research Institute of Texas in Houston; we are committed to finding the cure for kidney disease. Bill's Father, Henry William Gottfried, Jr., died early in his life from kidney failure and Bill has had other Family members afflicted by kidney disease. Danielle has had Family members suffer from kidney disease and kidney failure. Our goal is to raise investments that will be allocated directly to the leading kidney research and kidney dialysis technology innovation teams in Houston, around the U.S., and worldwide that are conducting leading edge research on finding the cure for kidney disease and improving patient care. Bill Gottfried has been involved in the biotechnology industry since the early 1980's, the dawn of the biotechnology era. He has supported biotechnology and health care investment in the U.S., Europe, and Asia, and he recruited the management team for the first biotechnology company that was established in Houston. Bill has provided capital formation, executive search, and strategic planning expertise to biotechnology industry clients for over 30 years. He was a founding member of BIOHouston and the Biotechnology Industry Organization in Washington, D.C. View all posts by Bill and Danielle Gottfried, Founders of The Kidney Research Institute of Texas